Clinical Trial Update: Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial update evaluating pembrolizumab in combination with INCB081776 and radiation therapy for head and neck squamous cell carcinoma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• INCB081776
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Head and Neck Squamous Cell Carcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING